Can A Dedicated Multidisciplinary Tumor Board Improve Personalized Medicine for Patients in Interventional Oncology? A Large Retrospective Single-Center Experience
Roberto IEZZI1,Bruno FIONDA2,Patrizia CORNACCHİONE2,Martina IEZZI3,Valentina LANCELLOTTA2,Andrea CONTEGIACOMO1,Fabia ATTILI4,Alberto LARGHI4,Francesco CELLINI2,Fabio MARAZZI2,Giuseppe COLLOCA2,Ángeles ROVIROSA5,György KOVÁCS6,Maria Antonietta GAMBACORTA2,Riccardo MANFREDI1,Vincenzo VALENTINI2,Luca TAGLIAFERRI2
1Department of Diagnostic Imaging, Fondazione Policlinico Universitario ?A. Gemelli? IRCCS, Radiation Oncology and Hematology, U.O.C. of Diagnostic and General Interventional Radiology, Rome-Italy
2Department of Diagnostic Imaging, Fondazione Policlinico Universitario ?A. Gemelli? IRCCS, Radiation Oncology and Hematology, U.O.C. of Radiation Oncology Therapy, Rome-Italy
3Sacred Heart Catholic University, Institute of Radiology, Rome-Italy
4Fondazione Policlinico Universitario ?A. Gemelli? IRCCS, Digestive Endoscopy Unit, Rome-Italy
5Department of Radiation Oncology, Hospital Clinic I Universitari, Barcelona-Spain
6Sacred Heart Catholic University, Educational Program Director Gemelli-INTERACTS, Rome-Italy
DOI : 10.5505/tjo.2022.2819 OBJECTIVE< br> Interventional oncology (IO) offers minimal invasive oncological procedures to personalize therapeutic approaches. We aimed at assessing potential advantages of an IO multidisciplinary tumor board (INTER-BOARD) in terms of waiting time, procedural adverse events, and length of hospital stay.

We retrospectively evaluated all patients managed at our institutional INTER-BOARD from January 2018 to June 2019. Outcome measurements such as number of patients managed in each semester, median interval time between initial assessment and admission to the hospital, total number of procedures, procedures type, adverse events, and complication-related days of hospital stay were analyzed.

The INTER-BOARD discussed 438 patients (mean age 64 years; range 27-92) during the study period. Overall, 203 procedures were performed in patients >65 years and 49 in patients >80 years. The number of patients discussed progressively increased over time 82 (18.7%) during the first semester, 120 (27.4%) during the second semester, and 236 (54.1%) in the third semester. Patients with 33 different cancer types were discussed and 22 different procedure types were performed. Mean hospitalization time was 4 days (progressively decreasing over time from 5 to 3 days). Adverse events occurred in 4% of cases, with a progressively decreasing rate over time (16%, 5%, and 3% for 1st, 2nd, and 3rd semester, respectively).

In our experience, the dedicated INTER-BOARD allowed optimization of patient care through critical evaluation of all treatment options offered by different specialists. This approach reached optimal treatment results, with low adverse events, and reduced waiting, as well as hospitalization time. Keywords : Brachytherapy; interventional oncology; interventional radiology; multidisciplinary team; personalized medicine; radiotherapy